Measurement of glycated hemoglobin
CA 2306840 A1 · Owner: Sanghera, Gordon · Inventors: Sanghera, Gordon; Ito, Ralph K.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention features a novel method of assaying glycated hemoglobin (GHb) in a sample using a capture molecule e.g. haptoglobin that binds GHb and hemoglobin (Hb), and detecting bound GHb with a molecule that distinguishes GHb from non-glycated hemoglobin (Hb). The molecule used to distinguish GHb from Hb may be an antibody. The assay and antibodies of the invention are useful for the evaluation of GHb in disease states such as diabetes.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 9, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 9, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 9, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.